Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CARA |
---|---|---|
09:32 ET | 186413 | 0.46 |
09:34 ET | 48624 | 0.457135 |
09:36 ET | 45302 | 0.4398 |
09:38 ET | 29739 | 0.445 |
09:39 ET | 33037 | 0.4499 |
09:41 ET | 25371 | 0.465 |
09:43 ET | 14704 | 0.465 |
09:45 ET | 35388 | 0.4701 |
09:48 ET | 17127 | 0.47 |
09:50 ET | 4620 | 0.4675 |
09:52 ET | 77246 | 0.4625 |
09:54 ET | 10050 | 0.46 |
09:56 ET | 102106 | 0.4501 |
09:57 ET | 19763 | 0.4481 |
09:59 ET | 3082 | 0.4499 |
10:01 ET | 38893 | 0.45 |
10:03 ET | 113704 | 0.45 |
10:06 ET | 23720 | 0.45 |
10:08 ET | 11081 | 0.4498 |
10:10 ET | 20660 | 0.4482 |
10:12 ET | 61786 | 0.4341 |
10:14 ET | 64379 | 0.4232 |
10:15 ET | 12351 | 0.4202 |
10:17 ET | 7512 | 0.43 |
10:19 ET | 46269 | 0.43 |
10:21 ET | 7801 | 0.4251 |
10:24 ET | 14465 | 0.425 |
10:26 ET | 19876 | 0.4202 |
10:28 ET | 4605 | 0.4257 |
10:30 ET | 15146 | 0.4226 |
10:32 ET | 197140 | 0.4237 |
10:33 ET | 11066 | 0.4238 |
10:35 ET | 6796 | 0.4227 |
10:37 ET | 24274 | 0.4238 |
10:39 ET | 15217 | 0.422775 |
10:42 ET | 5495 | 0.427668 |
10:44 ET | 22461 | 0.4277 |
10:46 ET | 11859 | 0.429899 |
10:48 ET | 12332 | 0.43 |
10:50 ET | 22743 | 0.4398 |
10:51 ET | 16718 | 0.4398 |
10:53 ET | 33665 | 0.4498 |
10:55 ET | 6287 | 0.4499 |
10:57 ET | 8485 | 0.45 |
11:00 ET | 14428 | 0.4499 |
11:02 ET | 107007 | 0.445 |
11:04 ET | 7556 | 0.445 |
11:06 ET | 10981 | 0.4449 |
11:08 ET | 5500 | 0.4499 |
11:09 ET | 5895 | 0.45 |
11:11 ET | 3493 | 0.45 |
11:13 ET | 3780 | 0.45 |
11:15 ET | 1641 | 0.45 |
11:18 ET | 1600 | 0.4452 |
11:20 ET | 4727 | 0.45 |
11:22 ET | 5158 | 0.44924 |
11:24 ET | 2660 | 0.449753 |
11:26 ET | 854 | 0.448972 |
11:27 ET | 10457 | 0.4451 |
11:29 ET | 1138 | 0.4498 |
11:31 ET | 158 | 0.4491 |
11:33 ET | 10082 | 0.448899 |
11:36 ET | 1848 | 0.449 |
11:38 ET | 480 | 0.4489 |
11:40 ET | 37531 | 0.4495 |
11:42 ET | 18196 | 0.446 |
11:44 ET | 29225 | 0.4477 |
11:45 ET | 14973 | 0.4475 |
11:47 ET | 14206 | 0.4498 |
11:49 ET | 2889 | 0.4497 |
11:51 ET | 26300 | 0.4428 |
11:54 ET | 17754 | 0.44 |
11:56 ET | 3302 | 0.4439 |
11:58 ET | 5641 | 0.44 |
12:00 ET | 25164 | 0.44 |
12:02 ET | 4915 | 0.4347 |
12:03 ET | 24578 | 0.4387 |
12:05 ET | 2313 | 0.4347 |
12:07 ET | 33801 | 0.4277 |
12:09 ET | 10673 | 0.4285 |
12:12 ET | 2768 | 0.4301 |
12:14 ET | 4541 | 0.4349 |
12:16 ET | 1253 | 0.4366 |
12:18 ET | 9723 | 0.4331 |
12:20 ET | 2261 | 0.4362 |
12:23 ET | 10699 | 0.4351 |
12:25 ET | 8780 | 0.435 |
12:27 ET | 5131 | 0.43505 |
12:30 ET | 11770 | 0.435 |
12:32 ET | 6083 | 0.4338 |
12:34 ET | 965 | 0.439 |
12:36 ET | 3276 | 0.4368 |
12:38 ET | 13180 | 0.436 |
12:39 ET | 9851 | 0.4307 |
12:41 ET | 1639 | 0.4357 |
12:43 ET | 10494 | 0.4401 |
12:45 ET | 8313 | 0.4448 |
12:48 ET | 42595 | 0.4329 |
12:50 ET | 10977 | 0.4329 |
12:52 ET | 13004 | 0.4307 |
12:54 ET | 17458 | 0.4329 |
12:56 ET | 5644 | 0.4329 |
12:57 ET | 11163 | 0.4384 |
12:59 ET | 5621 | 0.4434 |
01:01 ET | 1100 | 0.44 |
01:03 ET | 18485 | 0.4308 |
01:06 ET | 2817 | 0.4308 |
01:08 ET | 20756 | 0.4277 |
01:10 ET | 4659 | 0.434 |
01:12 ET | 26062 | 0.434 |
01:15 ET | 100 | 0.43515 |
01:17 ET | 574 | 0.435 |
01:19 ET | 7648 | 0.43745 |
01:21 ET | 600 | 0.437449 |
01:24 ET | 407 | 0.4384 |
01:26 ET | 2600 | 0.438 |
01:28 ET | 1891 | 0.4399 |
01:30 ET | 6227 | 0.44 |
01:32 ET | 200 | 0.4389 |
01:33 ET | 200 | 0.44 |
01:35 ET | 10100 | 0.4396 |
01:37 ET | 65942 | 0.4361 |
01:39 ET | 20033 | 0.4323 |
01:42 ET | 8796 | 0.433 |
01:44 ET | 1900 | 0.4368 |
01:48 ET | 529 | 0.4367 |
01:50 ET | 3321 | 0.4367 |
01:51 ET | 10992 | 0.43465 |
01:53 ET | 106 | 0.43465 |
01:55 ET | 3756 | 0.43465 |
01:57 ET | 1219 | 0.4374 |
02:00 ET | 901 | 0.43465 |
02:02 ET | 1871 | 0.4375 |
02:04 ET | 457 | 0.436434 |
02:06 ET | 2600 | 0.4319 |
02:08 ET | 2184 | 0.43465 |
02:09 ET | 2788 | 0.4319 |
02:11 ET | 335 | 0.43475 |
02:13 ET | 1842 | 0.4376 |
02:15 ET | 7422 | 0.4376 |
02:18 ET | 9159 | 0.4438 |
02:20 ET | 3736 | 0.4393 |
02:22 ET | 9458 | 0.4425 |
02:24 ET | 37873 | 0.4457 |
02:26 ET | 9202 | 0.44425 |
02:27 ET | 2000 | 0.4479 |
02:29 ET | 1214 | 0.448 |
02:31 ET | 18453 | 0.4438 |
02:33 ET | 4435 | 0.443 |
02:36 ET | 200 | 0.4443 |
02:38 ET | 2193 | 0.4414 |
02:40 ET | 34311 | 0.4416 |
02:42 ET | 1200 | 0.446 |
02:44 ET | 100 | 0.4445 |
02:45 ET | 2342 | 0.445615 |
02:47 ET | 2300 | 0.44305 |
02:49 ET | 200 | 0.4431 |
02:51 ET | 698 | 0.44305 |
02:54 ET | 4697 | 0.4445 |
02:56 ET | 7905 | 0.4442 |
02:58 ET | 2715 | 0.4431 |
03:00 ET | 2100 | 0.44505 |
03:02 ET | 525 | 0.4446 |
03:03 ET | 3966 | 0.446 |
03:05 ET | 3394 | 0.44475 |
03:07 ET | 11661 | 0.4446 |
03:09 ET | 200 | 0.445 |
03:12 ET | 17044 | 0.4447 |
03:14 ET | 26308 | 0.4453 |
03:16 ET | 3584 | 0.4444 |
03:18 ET | 1231 | 0.4452 |
03:20 ET | 7888 | 0.44105 |
03:21 ET | 1350 | 0.4419 |
03:23 ET | 2893 | 0.4412 |
03:25 ET | 980 | 0.445 |
03:27 ET | 2543 | 0.4438 |
03:30 ET | 1750 | 0.442601 |
03:32 ET | 2689 | 0.4428 |
03:34 ET | 4100 | 0.4428 |
03:36 ET | 412 | 0.44365 |
03:38 ET | 1568 | 0.444 |
03:39 ET | 361 | 0.44405 |
03:41 ET | 27054 | 0.445 |
03:43 ET | 3650 | 0.4443 |
03:45 ET | 25990 | 0.4439 |
03:48 ET | 12034 | 0.4444 |
03:50 ET | 1141 | 0.444 |
03:52 ET | 5365 | 0.444 |
03:54 ET | 3434 | 0.445 |
03:56 ET | 21208 | 0.4451 |
03:57 ET | 22781 | 0.4452 |
03:59 ET | 29037 | 0.4436 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cara Therapeutics Inc | 37.2M | -0.2x | --- |
ImmuCell Corp | 33.4M | -8.4x | --- |
Aadi Bioscience Inc | 41.7M | -0.7x | --- |
Aligos Therapeutics Inc | 39.8M | -0.3x | --- |
Turnstone Biologics Corp | 65.7M | -0.8x | --- |
SQZ Biotechnologies Co | 884.7K | 0.0x | --- |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $37.2M |
---|---|
Revenue (TTM) | $16.9M |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-2.26 |
Book Value | $1.05 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -729.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.